---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-315151"
form_type: "8-K"
ticker: "HCA"
cik: "0000860730"
company_name: "HCA Healthcare, Inc."
filed_at: "2026-07-24T11:45:42+00:00"
generated_at: "2026-07-24T11:50:17.217121+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# HCA Healthcare Q2 revenue $20.23B (+8.7%), EPS $7.62 (+11.6%); declares $0.78 dividend

## Summary
- Revenue $20.23B (+8.7% YoY); net income $1.699B (+2.8%); diluted EPS $7.62 (+11.6%).
- Adjusted EBITDA $4.027B (+4.6%); same facility admissions +2.5%, equivalent admissions +2.7%.
- Payer mix shift from uninsured volume had ~$400M unfavorable pre-tax impact; offset by ~$400M net benefit from Medicaid Supplemental Payment Programs (Florida).
- Cash flows from operations $2.335B vs $4.210B in prior year (down 44.5%).
- Board declared quarterly dividend $0.78/share, payable Sept 30, 2026 to holders of record Sept 16, 2026.

## SEC filing metadata
- accession: 0001193125-26-315151
- form_type: 8-K
- ticker: HCA
- cik: 0000860730
- company_name: HCA Healthcare, Inc.
- filed_at: 2026-07-24T11:45:42+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/860730/000119312526315151/0001193125-26-315151-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/860730/000119312526315151/hca-20260724.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-315151
- JSON: https://secwatch.observer/filing/0001193125-26-315151.json
- Plain text: https://secwatch.observer/filing/0001193125-26-315151.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.